Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jan;1(1):71-82.
doi: 10.2217/cer.11.10.

Comparative effectiveness research in chronic obstructive pulmonary disease

Review

Comparative effectiveness research in chronic obstructive pulmonary disease

Richard A Mularski et al. J Comp Eff Res. 2012 Jan.

Abstract

Chronic obstructive pulmonary disease affects millions worldwide. It is America's third leading cause of death, and results in significant morbidity and cost. Although many therapies exist and are being developed to alleviate symptoms and decrease morbidity and mortality in chronic obstructive pulmonary disease, most have only been studied in placebo-controlled efficacy studies in highly selected populations. Comparative effectiveness and translational research in chronic obstructive pulmonary disease will require the development of infrastructures to support collaboration between researchers and the stakeholders who generate, disseminate and use new knowledge. Methodologies need to evolve to both prioritize research questions and to conduct collaborative comparative effectiveness research studies. Given the impracticality of testing every clinical intervention in comparative pragmatic trials for comparative effectiveness research in chronic obstructive pulmonary disease, we advocate expanding methodology that includes the use of observational databases with serially performed effectiveness analyses and quasi-experimental designs that include following healthcare changes longitudinally over time to assess benefit, harm, subgroups and cost.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Translational research model
Efficacy (T2) leads to innovation while effectiveness and implementation (T3) lead to health improvement.
Figure 2
Figure 2. Processes of care and summary measures at each CONCERT site
CONCERT: Chronic obstructive pulmonary disease Outcomes-based Network for Clinical Effectiveness and Research Translation.

Similar articles

Cited by

References

    1. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance: United States, 1971–2000. MMWR Surveill Summ. 2002;51(6):1–16. - PubMed
    1. Medicare Payment Advisory Commission. Report to the Congress: Promoting Greater Efficiency in Medicare. MEDPAC; Washington, DC, USA: 2007.
    1. Toy EL, Gallagher KF, Stanley EL, Swensen AR, Duh MS. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review. COPD. 2010;7(3):214–228. - PubMed
    1. Lindenauer PK, Pekow P, Gao S, Crawford AS, Gutierrez B, Benjamin EM. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2006;144(12):894–903. - PubMed
    1. Foster TS, Miller JD, Marton JP, Caloyeras JP, Russell MW, Menzin J. Assessment of the economic burden of COPD in the US: a review and synthesis of the literature. COPD. 2006;3(4):211–218. - PubMed

Websites

    1. [Accessed 27 August 2011];NHLBI morbidity and mortality chartbook. www.nhlbi.nih.gov/resources/docs/cht-book.htm.
    1. [Accessed 27 August 2011];FASTSTATS: chronic lower respiratory disease. www.cdc.gov/nchs/fastats/copd.htm.
    1. HCUP nationwide inpatient sample (NIS) Healthcare cost and utilization project (HCUP) 2000–2006. Agency for Healthcare Research and Quality; Rockville, MD, USA: www.hcup-us.ahrq.gov/nisoverview.jsp. - PubMed
    1. [Accessed 21 June 2011];HCUPnet: a tool for identifying, tracking, and analyzing national hospital statistics. http://hcupnet.ahrq.gov.
    1. [Accessed 21 June 2011];Global strategy for the diagnosis, management and prevention of COPD: global initiative for chronic obstructive lung disease (GOLD) www.goldcopd.org.

Publication types

MeSH terms